Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 221050-89-1 | MDL No. : | MFCD26383921 |
Formula : | C13H20N4O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KQDGVJCIWVOYPX-UHFFFAOYSA-N |
M.W : | 264.32 | Pubchem ID : | 18468741 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.62 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 79.23 |
TPSA : | 58.56 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.98 cm/s |
Log Po/w (iLOGP) : | 2.66 |
Log Po/w (XLOGP3) : | 1.32 |
Log Po/w (WLOGP) : | 0.77 |
Log Po/w (MLOGP) : | 0.85 |
Log Po/w (SILICOS-IT) : | 0.58 |
Consensus Log Po/w : | 1.24 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.28 |
Solubility : | 1.39 mg/ml ; 0.00525 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.15 |
Solubility : | 1.87 mg/ml ; 0.00707 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.34 |
Solubility : | 1.22 mg/ml ; 0.00461 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.51 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 221050-88-0 ]
tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate
Similarity: 0.89
[ 153747-97-8 ]
tert-Butyl 4-(5-bromopyridin-2-yl)piperazine-1-carboxylate
Similarity: 0.76
[ 849751-48-0 ]
tert-Butyl (2-chloropyrimidin-4-yl)carbamate
Similarity: 0.75
[ 111669-25-1 ]
1-Boc-4-(3-Aminopyridin-2-yl)piperazine
Similarity: 0.74
[ 634468-96-5 ]
tert-Butyl 4-(pyrimidin-5-yl)piperazine-1-carboxylate
Similarity: 0.74
[ 221050-88-0 ]
tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate
Similarity: 0.89
[ 153747-97-8 ]
tert-Butyl 4-(5-bromopyridin-2-yl)piperazine-1-carboxylate
Similarity: 0.76
[ 111669-25-1 ]
1-Boc-4-(3-Aminopyridin-2-yl)piperazine
Similarity: 0.74
[ 634468-96-5 ]
tert-Butyl 4-(pyrimidin-5-yl)piperazine-1-carboxylate
Similarity: 0.74
[ 571188-59-5 ]
tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
Similarity: 0.72
[ 221050-88-0 ]
tert-Butyl 4-(2-chloropyrimidin-4-yl)piperazine-1-carboxylate
Similarity: 0.89
[ 849751-48-0 ]
tert-Butyl (2-chloropyrimidin-4-yl)carbamate
Similarity: 0.75
[ 634468-96-5 ]
tert-Butyl 4-(pyrimidin-5-yl)piperazine-1-carboxylate
Similarity: 0.74
[ 374930-88-8 ]
tert-Butyl 4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate
Similarity: 0.69
[ 147539-23-9 ]
1-Boc-4-(6-Chloro-5-nitro-4-pyrimidinyl)piperazine
Similarity: 0.69